Other articles of interest

Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness

Marc Llagostera-Martín, Miguel Cainzos, Neus Salvatella, Héctor Cubero-Gallego, Aleksandra Mas-Stachurska, Andrea Sánchez-Carpintero, Helena Tizón-Marcos, Alicia Calvo-Fernández, Luis Molina, Beatriz Vaquerizo,

Rev Esp Cardiol. 2024;77:150-7
ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium

Francisco José Bermúdez-Jiménez, Víctor Carriel, Juan José Santos-Mateo, Adrián Fernández, Soledad García-Hernández, Karina Analía Ramos, Jesús Piqueras-Flores, Eva Cabrera-Romero, Roberto Barriales-Villa, Luis de la Higuera Romero, Juan Emilio Alcalá López, Juan Ramón Gimeno Blanes, David Sánchez-Porras, Fernando Campos, Miguel Alaminos, José Manuel Oyonarte-Ramírez, Miguel Álvarez, Luis Tercedor, Andreas Brodehl, Juan Jiménez-Jáimez,

Rev Esp Cardiol. 2023;76:301-11
Bleeding and embolic risk in patients with atrial fibrillation and cancer

Sergio Raposeiras-Roubín, Emad Abu-Assi, Tamara Fernández Sanz, Cristina Barreiro Pardal, Isabel Muñoz Pousa, Maria Melendo Viu, Pablo Domínguez Erquicia, Ana Ledo Piñeiro, Andrea Lizancos Castro, Inmaculada González Bermúdez, Xavier Rosselló, Borja Ibáñez, Andrés Íñiguez Romo,

Rev Esp Cardiol. 2023;76:344-52